Our Clinical Trials

V201 Study

Flu

Lakeland Clinical Trials is conducting a clinical trial to evaluate the safety and efficacy of different formulations of MF59-Adjuvanted Quadrivalent Subunit Inactivated Cell-derived Influenza Vaccine (aQIVc) in Older Adults ≥50 Years of Age  You may be eligible to participate if:

Lakeland Clinical Trials is conducting a clinical trial to evaluate the safety and efficacy of different formulations of MF59-Adjuvanted Quadrivalent Subunit Inactivated Cell-derived Influenza...

View Study

CARE Study

Lakeland Clinical Trials is conducting a clinical trial to compare two different asthma inhalers in the treatment of childhood asthma. You may be eligible to participate if:

Lakeland Clinical Trials is conducting a clinical trial to compare two different asthma inhalers in the treatment of childhood asthma. You may be eligible to participate if: You are aged...

View Study

Ka Matau, Ka Ora Study

Lakeland Clinical Trials is conducting a clinical trial to investigate the immune response (the body's natural defence mechanism) to the Pfizer-BioNTech COVID-19 vaccine in the New Zealand population. You may be eligible to participate if:

Lakeland Clinical Trials is conducting a clinical trial to investigate the immune response (the body's natural defence mechanism) to the Pfizer-BioNTech COVID-19 vaccine in the New Zealand population...

View Study

ENANTA Study

NOW ENROLLING: A NEW STUDY OF A 5 DAY DOSE OF INVESTIGATIONAL ORAL MEDICATION FOR THE TREATMENT OF COLD AND FLU -LIKE SYMPTOMS CAUSED BY RESPIRATORY SYNCYTIAL VIRUS (RSV) Lakeland Clinical Trials is conducting a clinical trial to investigate a new medication for RSV

NOW ENROLLING: A NEW STUDY OF A 5 DAY DOSE OF INVESTIGATIONAL ORAL MEDICATION FOR THE TREATMENT OF COLD AND FLU -LIKE SYMPTOMS CAUSED BY RESPIRATORY SYNCYTIAL VIRUS (RSV) Lakeland Clinical Trials...

View Study

Pages